Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study

Cancer Epidemiology

Volumn 35, Issue 6, 2011, Pages

  Schonfeld, S J ^a   Ron, E ^a   Kitahara, C M ^a   Brenner, A ^a   Park, Y ^a   Sigurdson, A J ^a   Schatzkin, A ^a   González, A Berrington De ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Benign breast disease; Hormonal and related risk factors; Postmenopausal; Reproductive; Thyroid endocrine related cancer

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; BENIGN TUMOR; BREAST DISEASE; CANCER RISK; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID UNDIFFERENTIATED CARCINOMA;

AGED; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENARCHE; MENOPAUSE; MIDDLE AGED; PARITY; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; REPRODUCTIVE HISTORY; RISK FACTORS; THYROID NEOPLASMS;

EID: 81055156221     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.05.009     Document Type: Article

References (29)

1. American Cancer Society Facts and Figures 2010. Atlanta: American Cancer Society; 2010.
2. Dal Maso L., Bosetti C., La Vecchia C., Franceschi S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Cause Control 2009, 20(FEBRUARY (1)):75-86.
3. GLOBOCAN Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet] 2008, International Agency for Research on Cancer 2010, http://globocan.iarc.fr (accessed 6.12.10), Lyon, France.
4. Kilfoy B.A., Devesa S.S., Ward M.H., Zhang Y., Rosenberg P.S., Holford T.R., et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 2009, 18(APRIL (4)):1092-1100.
5. Fleury Y., Van Melle G., Woringer V., Gaillard R.C., Portmann L. Sex-dependent variations and timing of thyroid growth during puberty. J Clin Endocrinol Metab 2001, 86(FEBRUARY (2)):750-754.
6. Berghout A., Wiersinga W. Thyroid size thyroid function during pregnancy: an analysis. Eur J Endocrinol 1998, 138(MAY (5)):536-542.
7. Hegedus L., Karstrup S., Rasmussen N. Evidence of cyclic alterations of thyroid size during the menstrual cycle in healthy women. Am J Obstet Gynecol 1986, 155(JULY (1)):142-145.
8. Chen G.G., Vlantis A.C., Zeng Q., van Hasselt C.A. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 2008, 8(AUGUST (5)):367-377.
9. Navarro Silvera S.A., Miller A.B., Rohan T.E. Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer 2005, 116(SEPTEMBER(3)):433-438.
10. Akslen L.A., Nilssen S., Kvale G. Reproductive factors and risk of thyroid cancer. A prospective study of 63,090 women from Norway. Br J Cancer 1992, 65(MAY (5)):772-774.
11. La Vecchia C., Ron E., Franceschi S., Dal Maso L., Mark S.D., Chatenoud L., et al. A pooled analysis of case-control studies of thyroid cancer III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 1999, 10(APRIL (2)):157-166.
12. Negri E., Dal Maso L., Ron E., La Vecchia C., Mark S.D., Preston-Martin S., et al. A pooled analysis of case-control studies of thyroid cancer II. Menstrual and reproductive factors. Cancer Causes Control 1999, 10(APRIL (2)):143-155.
13. Meinhold C.L., Ron E., Schonfeld S.J., Alexander B.H., Freedman D.M., Linet M.S., et al. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 2010, 171(JAN (2)):242-252.
14. Iribarren C., Haselkorn T., Tekawa I.S., Friedman G.D. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 2001, 93(SEPTEMBER(5)):745-750.
15. Negri E., Ron E., Franceschi S., Dal Maso L., Mark S.D., Preston-Martin S., et al. A pooled analysis of case-control studies of thyroid cancer. I. Methods. Cancer Causes Control 1999, 10(APRIL (2)):131-142.
16. Enewold L., Zhu K., Ron E., Marrogi A.J., Stojadinovic A., Peoples G.E., et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 2009, 18(March (3)):784-791.
17. Schatzkin A., Subar A.F., Thompson F.E., Harlan L.C., Tangrea J., Hollenbeck A.R., et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001, 154(DECEMBER (12)):1119-1125.
18. Fritz A.G. International classification of diseases for oncology: ICD-O 2000, World Health Organization, Geneva. 3rd ed.
19. Meinhold C.L., Park Y., Stolzenberg-Solomon R.Z., Hollenbeck A.R., Schatzkin A., Berrington de Gonzalez A. Alcohol intake and risk of thyroid cancer in the NIH-AARP Diet and Health Study. Br J Cancer 2009, 101(NOVEMBER (9)):1630-1634.
20. Leitzmann M.F., Brenner A., Moore S.C., Koebnick C., Park Y., Hollenbeck A., et al. Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer 2010, 126(JUNE (12)):2947-2956.
21. Preston-Martin S., Franceschi S., Ron E., Negri E. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned?. Cancer Causes Control 2003, 14(October (8)):787-789.
22. Gerstman B.B., Gross T.P., Kennedy D.L., Bennett R.C., Tomita D.K., Stadel B.V. Trends in the content and use of oral contraceptives in the United States, 1964-1988. Am J Public Health 1991, 81(JANuary (1)):90-96.
23. Hard G.C. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ Health Perspect 1998, 106(AUGUST (8)):427-436.
24. Tahboub R., Arafah B.M. Sex steroids and the thyroid. Best Pract Res Clin Endocrinol Metab 2009, 23(DECEMBER (6)):769-780.
25. Ronckers C.M., McCarron P., Ron E. Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 2005, 117(NOVEMBER (2)):281-288.
26. Bhargav P.R., Mishra A., Agarwal G., Agarwal A., Verma A.K., Mishra S.K. Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. World J Surg 2009, 33(October (10)):2087-2093.
27. Giustarini E., Pinchera A., Fierabracci P., Roncella M., Fustaino L., Mammoli C., et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol 2006, 154(MAY (5)):645-649.
28. Hartmann L.C., Sellers T.A., Frost M.H., Lingle W.L., Degnim A.C., Ghosh K., et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005, 353(JULY (3)):229-237.
29. Sipos J.A., Mazzaferri E.L. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010, 22(AUGUST (6)):395-404.